HCA Healthcare, Inc. Quarterly Report for Q1 Ended Mar 31, 2018

Summary

HCA Healthcare, Inc. reported strong financial performance for the first quarter of 2018, with revenues increasing by 7.5% year-over-year to $11.423 billion. Net income attributable to HCA Healthcare, Inc. saw a significant increase of 73.5% to $1.144 billion, or $3.18 per diluted share, compared to $659 million, or $1.74 per diluted share, in the prior year period. This robust growth was driven by a combination of increased patient volumes (equivalent admissions up 4.6%) and higher revenue per equivalent admission (up 2.9%). The company also benefited from a substantial one-time gain of $405 million from the sale of facilities and a lower effective tax rate due to the Tax Cuts and Jobs Act. Operationally, HCA demonstrated consistent volume growth across key metrics, including admissions and emergency department visits. The company also continued its strategic initiatives, including acquisitions and share repurchases, while managing its capital structure effectively. Despite facing ongoing healthcare industry challenges, HCA's performance indicates strong operational execution and favorable market dynamics in the reported quarter.

Key Highlights

• 1Revenues increased 7.5% to $11.423 billion in Q1 2018 compared to Q1 2017.
• 2Net income attributable to HCA Healthcare, Inc. surged by 73.5% to $1.144 billion ($3.18 per diluted share) in Q1 2018.
• 3The company recorded a significant pre-tax gain of $405 million from the sale of facilities during the quarter.
• 4Effective tax rate decreased significantly to 18.4% in Q1 2018 from 30.4% in Q1 2017, primarily due to the Tax Cuts and Jobs Act.
• 5Consolidated admissions increased by 4.6% and revenue per equivalent admission rose by 2.9% year-over-year.
• 6Cash flows from operating activities remained strong, increasing slightly to $1.300 billion in Q1 2018.
• 7HCA repurchased $423 million of its common stock and declared a quarterly dividend of $0.35 per share.

Frequently Asked Questions